Filing Details
- Accession Number:
- 0001562180-20-005448
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-14 18:27:13
- Reporting Period:
- 2020-01-27
- Accepted Time:
- 2020-08-14 18:27:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1459839 | Si-Bone Inc. | SIBN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1296771 | Gordon John Freund | C/O Skyline Ventures 525 University Avenue, Suite 1350 Palo Alto CA 94301 | No | No | No | No | |
1419187 | Skyline Venture Partners V Lp | 525 University Avenue, Suite 1350 Palo Alto CA 94301 | No | No | No | No | |
1434887 | Skyline Venture Management V, Llc | 525 University Avenue, Suite 1350 Palo Alto CA 94301 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-27 | 1,000,000 | $21.50 | 2,819,985 | No | 4 | S | Indirect | By Skyline Venture Partners V, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Skyline Venture Partners V, LP |
Footnotes
- Shares are sold in the conjunction with SI-BONE, INC's public offering of common stock announced on January 21st, 2020.
- Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, is a managing director of LLC and may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Although each of SVP V and LLC have ceased to be subject to the reporting requirements of Section 16 as a result of this sale of shares and the public offering, Dr. Freund is a director of SI-BONE, Inc. and, accordingly, remains subject to the reporting requirements of Section 16.